{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:49:26Z","timestamp":1753890566574,"version":"3.41.2"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T00:00:00Z","timestamp":1643328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>We have proposed the Taiwan AF score consisting of age, male sex, hypertension, heart failure, coronary artery disease, end-stage renal disease, and alcoholism to predict incident atrial fibrillation (AF) in Asian population. We hypothesized that the modified Taiwan AF score (mTaiwan AF score) excluding alcoholism remained useful for predicting new onset AF.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A total of 7,220,654 subjects aged \u2265 40 years without a past history of cardiac arrhythmia were identified from a national cohort, and 438,930 incident AF occurred during a 16-year follow-up with an incidence of 0.42 per 100 person-years. The mTaiwan AF score ranging between \u22122 and 14 and its predictive accuracy of incident AF was analyzed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The areas under the receiver operating characteristic curve (AUCs) of the mTaiwan AF scores in predicting AF are 0.861 for 1-year follow-up, 0.829 for 5-year follow-up, 0.795 for 10-year follow-up, and 0.751 for 16-year follow-up. The risk of incident AF increased from 0.05%\/year for patients with a score of \u22122 to 6.98%\/year for those having a score of 14. Patients were classified into three groups based on the tertile values of the mTaiwan AF scores\u2014group 1 (score \u22122-3), group 2 (score 4-9) and group 3 (score 10-14). The annual risks of incident AF were 0.20, 1.33, and 3.36% for group 1, 2, and 3, respectively. Compared to patients in group 1, the hazard ratios of incident AF were 5.79 [95% confidence interval (CI) 3.75-7.75] for group 2 and 8.93 (95% CI 6.47-10.80) for group 3.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>We demonstrated that the mTaiwan AF score based on age and clinical comorbidities could be used to predict incident AF in Asian population.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcvm.2021.805399","type":"journal-article","created":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T06:15:50Z","timestamp":1643350550000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Modified Taiwan Atrial Fibrillation Score for the Prediction of Incident Atrial Fibrillation"],"prefix":"10.3389","volume":"8","author":[{"given":"Jo-Nan","family":"Liao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su-Shen","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tzeng-Ji","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ta-Chuan","family":"Tuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shih-Ann","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tze-Fan","family":"Chao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,1,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1136\/hrt.2006.110791","article-title":"Atrial fibrillation\u2013the growing epidemic","volume":"93","author":"Lip","year":"2007","journal-title":"Heart"},{"key":"B2","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1161\/CIRCULATIONAHA.113.005119","article-title":"Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study","volume":"129","author":"Chugh","year":"2014","journal-title":"Circulation"},{"key":"B3","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.chest.2017.10.001","article-title":"Lifetime risks, projected numbers, and adverse outcomes in Asian patients with atrial fibrillation: a report from the Taiwan nationwide AF cohort study","volume":"153","author":"Chao","year":"2018","journal-title":"Chest"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1016\/j.hrthm.2013.03.017","article-title":"Stroke prevention in atrial fibrillation\u2013an Asian stroke perspective","volume":"10","author":"Tse","year":"2013","journal-title":"Heart Rhythm"},{"key":"B5","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/nrcardio.2014.118","article-title":"Global epidemiology of atrial fibrillation","volume":"11","author":"Rahman","year":"2014","journal-title":"Nat Rev Cardiol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ahj.2018.04.017","article-title":"10-year nationwide trends of the incidence, prevalence, and adverse outcomes of non-valvular atrial fibrillation nationwide health insurance data covering the entire Korean population","volume":"202","author":"Kim","year":"2018","journal-title":"Am Heart J"},{"key":"B7","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S0140-6736(09)60443-8","article-title":"Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study","volume":"373","author":"Schnabel","year":"2009","journal-title":"Lancet"},{"key":"B8","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.amjcard.2010.08.049","article-title":"A clinical risk score for atrial fibrillation in a biracial prospective cohort (from the Atherosclerosis Risk in Communities [ARIC] study)","volume":"107","author":"Chamberlain","year":"2011","journal-title":"Am J Cardiol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e000102","DOI":"10.1161\/JAHA.112.000102","article-title":"Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: the CHARGE-AF consortium","volume":"2","author":"Alonso","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e020194","DOI":"10.1161\/JAHA.120.020194","article-title":"Clinical risk score for the prediction of incident atrial fibrillation: derivation in 7 220 654 Taiwan patients with 438 930 incident atrial fibrillations during a 16-year follow-up","volume":"2021","author":"Chao","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1093\/eurheartj\/ehy837","article-title":"Age threshold for the use of non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with atrial fibrillation: insights into the optimal assessment of age and incident comorbidities","volume":"40","author":"Chao","year":"2019","journal-title":"Eur Heart J"},{"key":"B12","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1161\/CIRCULATIONAHA.117.031658","article-title":"Oral anticoagulation in very elderly patients with atrial fibrillation: a nationwide cohort study","volume":"138","author":"Chao","year":"2018","journal-title":"Circulation"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-021-01816-z","article-title":"Continuation or discontinuation of oral anticoagulants after HAS-BLED scores increase in patients with atrial fibrillation","author":"Chao","year":"2021","journal-title":"Clin Res Cardiol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.hrthm.2021.02.018","article-title":"Oral anticoagulants in extremely-high-risk, very elderly (>90 years) patients with atrial fibrillation","volume":"18","author":"Chao","year":"2021","journal-title":"Heart Rhythm"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1093\/ehjqcco\/qcab050","article-title":"Should oral anticoagulants still be prescribed to patients with atrial fibrillation with a single stroke risk factor but at high bleeding risk? a nationwide cohort study","author":"Chao","year":"2021","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"B16","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.mayocp.2020.08.042","article-title":"Non-vitamin K antagonist oral anticoagulants in elderly (>\/=85 years) patients with newly diagnosed atrial fibrillation: changing clinical practice and outcomes for stroke prevention in a nationwide cohort study","volume":"96","author":"Cheng","year":"2021","journal-title":"Mayo Clin Proc"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e13488","DOI":"10.1111\/eci.13488","article-title":"Non-vitamin K antagonist oral anticoagulants versus warfarin in AF patients >\/= 85 years","volume":"51","author":"Tsai","year":"2021","journal-title":"Eur J Clin Invest"},{"key":"B18","doi-asserted-by":"publisher","first-page":"157","DOI":"10.29828\/JFMA.200503.0002","article-title":"Accuracy of diabetes diagnosis in health insurance claims data in Taiwan","volume":"104","author":"Lin","year":"2005","journal-title":"J Formos Med Assoc"},{"key":"B19","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/pds.2087","article-title":"Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan","volume":"20","author":"Cheng","year":"2011","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"B20","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.atherosclerosis.2013.11.036","article-title":"Continuation of statin therapy and a decreased risk of atrial fibrillation\/flutter in patients with and without chronic kidney disease","volume":"232","author":"Chang","year":"2014","journal-title":"Atherosclerosis"},{"key":"B21","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1161\/CIRCULATIONAHA.114.014508","article-title":"Transparent reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): the TRIPOD statement","volume":"162","author":"Collins","year":"2015","journal-title":"Ann Intern Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1002\/sim.1742","article-title":"Presentation of multivariate data for clinical use: the Framingham Study risk score functions","volume":"23","author":"Sullivan","year":"2004","journal-title":"Stat Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e257","DOI":"10.1161\/CIRCULATIONAHA.106.177292","article-title":"ACC\/AHA\/ESC 2006 Guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the (2001) Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society","volume":"114","author":"Fuster","year":"2006","journal-title":"Circulation"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1161\/01.CIR.0000140263.20897.42","article-title":"Lifetime risk for development of atrial fibrillation: the Framingham Heart Study","volume":"110","author":"Lloyd-Jones","year":"2004","journal-title":"Circulation"},{"key":"B25","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1161\/CIRCEP.112.970749","article-title":"Distribution and risk profile of paroxysmal, persistent, and permanent atrial fibrillation in routine clinical practice: insight from the real-life global survey evaluating patients with atrial fibrillation international registry","volume":"5","author":"Chiang","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e63479","DOI":"10.1371\/journal.pone.0063479","article-title":"Risk profiles and antithrombotic treatment of patients newly diagnosed with atrial fibrillation at risk of stroke: perspectives from the international, observational, prospective GARFIELD registry","volume":"8","author":"Kakkar","year":"2013","journal-title":"PLoS ONE"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1038\/ki.2014.393","article-title":"Incidence and risk factors for new-onset atrial fibrillation among patients with end-stage renal disease undergoing renal replacement therapy","volume":"87","author":"Liao","year":"2015","journal-title":"Kidney Int"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.1016\/j.jacc.2016.08.074","article-title":"Alcohol and atrial fibrillation: a sobering review","volume":"68","author":"Voskoboinik","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/0002-8703(78)90296-X","article-title":"Arrhythmias and the \u201cHoliday Heart\u201d: alcohol-associated cardiac rhythm disorders","volume":"95","author":"Ettinger","year":"1978","journal-title":"Am Heart J"},{"key":"B30","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.jacc.2014.03.048","article-title":"Alcohol consumption and risk of atrial fibrillation: a prospective study and dose-response meta-analysis","volume":"64","author":"Larsson","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.jacc.2010.08.641","article-title":"Alcohol consumption and risk of atrial fibrillation: a meta-analysis","volume":"57","author":"Kodama","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1097\/HJR.0b013e32833a1947","article-title":"Alcohol consumption as a risk factor for atrial fibrillation: a systematic review and meta-analysis","volume":"17","author":"Samokhvalov","year":"2010","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1093\/eurheartj\/ehaa953","article-title":"Alcohol consumption, cardiac biomarkers, and risk of atrial fibrillation and adverse outcomes","volume":"42","author":"Csengeri","year":"2021","journal-title":"Eur Heart J"},{"key":"B34","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1253\/circj.CJ-13-1387","article-title":"Heavy alcohol consumption and risk of atrial fibrillation. The Circulatory Risk in Communities Study (CIRCS)","volume":"78","author":"Sano","year":"2014","journal-title":"Circ J"},{"key":"B35","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ijcard.2017.05.133","article-title":"Alcohol and incident atrial fibrillation - a systematic review and meta-analysis","volume":"246","author":"Gallagher","year":"2017","journal-title":"Int J Cardiol"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2021.805399\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T06:15:54Z","timestamp":1643350554000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2021.805399\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,28]]},"references-count":35,"alternative-id":["10.3389\/fcvm.2021.805399"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2021.805399","relation":{},"ISSN":["2297-055X"],"issn-type":[{"type":"electronic","value":"2297-055X"}],"subject":[],"published":{"date-parts":[[2022,1,28]]},"article-number":"805399"}}